Abstract
Background: Equine glandular gastric disease (EGGD) is an erosive disease of the glandular mucosa of the stomach, which is increasingly recognised as a potential cause of poor performance, girthing pain and behavioural changes in sport horses. Unfortunately, the cause of EGGD has not yet been identified, and thus targeted treatment is not possible. Therefore, current recommendations for treatment and prevention are based on acid suppression and management strategies aimed at mitigating known risk factors.Aim of the article: This article summarises what we currently know about EGGD and outlines how we can use this information to manage the disease more effectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
